
Novel ингибитор of PD-1/PD-L1 (IC 50 value of 56.58 nM), dose-dependently promoting HepG2 клетка death in a co-culture model of HepG2/hPD-L1 and Jurkat T cells, effectively inhibiting tumor growth (TGI of 76.4% at 90 mg/kg) in an immune checkpoint humanized
Novel inhibitor of PD-1/PD-L1 (IC 50 value of 56.58 nM), dose-dependently promoting HepG2 cell death in a co-culture model of HepG2/hPD-L1 and Jurkat T cells, effectively inhibiting tumor growth (TGI of 76.4% at 90 mg/kg) in an immune checkpoint humanized
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.